[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fUy2PPETyQ8etW8CbiNSvYJ3-sOEIHPqebkW_lzVJYp4":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":13,"question":20,"related":21,"source":32,"type":33},[],"2023-12-25 16:05:14",121314339,[8,9,10,11,12],"诱导免疫耐受","抑制超敏反应","裂解细菌","启动抗体的类别转换","结合细胞毒性T细胞",{"count":14,"courseId":15,"courseImg":16,"courseName":17,"workId":18,"workName":19},45,"efd77d9400f449c7f6c7e8dd3e1cd3c6","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F4dbf347d0836be8909524c26223d7a64.jpg","【23秋】医学免疫学（1）","fec929baf3204ea8813c9a834c71d9b7","补体系统(单选题)","补体系统在激活后可以",[22,34,37,47,57,67,75,80,86,96],{"answer":23,"createTime":5,"id":24,"options":25,"question":31,"source":32,"type":33},[],121314337,[26,27,28,29,30],"IgG","IgM","IgD","LPS","MBL","参与旁路途径激活补体的物质是","v1",0,{"answer":35,"createTime":5,"id":6,"options":36,"question":20,"source":32,"type":33},[],[8,9,10,11,12],{"answer":38,"createTime":5,"id":39,"options":40,"question":46,"source":32,"type":33},[],121314341,[41,42,43,44,45],"C2b","C3b","C5b","C2a","C4a","具有调理吞噬作用的补体裂解产物是",{"answer":48,"createTime":5,"id":49,"options":50,"question":56,"source":32,"type":33},[],121314345,[51,52,53,54,55],"C3","C5","C1","C4","C9","补体固有成分中分子量最大的是",{"answer":58,"createTime":59,"id":60,"options":61,"question":66,"source":32,"type":33},[],"2023-12-25 16:05:15",121314346,[62,63,64,54,65],"C1q","C1r","C1s","C2","在经典激活途径中,补体的识别单位是",{"answer":68,"createTime":59,"id":69,"options":70,"question":74,"source":32,"type":33},[],121314347,[62,71,51,72,73],"C4和C2","B因子","D因子","同时参与补体三种激活途径的成分是",{"answer":76,"createTime":59,"id":77,"options":78,"question":79,"source":32,"type":33},[],121314350,[53,55,72,51,52],"血清中含量最高的补体固有成分是",{"answer":81,"createTime":59,"id":82,"options":83,"question":85,"source":32,"type":33},[],121314351,[73,72,53,51,84],"P因子","以下不参与旁路激活途径的是",{"answer":87,"createTime":59,"id":88,"options":89,"question":95,"source":32,"type":33},[],121314352,[90,91,92,93,94],"三条途径的膜攻击复合物相同","旁路途径在感染后期发挥作用","经典途径从C1激活开始","旁路途径从C3激活开始","MBL途径中形成的C3转化酶是C4b2a","关于补体三条激活途径描述错误的是",{"answer":97,"createTime":59,"id":98,"options":99,"question":105,"source":32,"type":33},[],121314353,[100,101,102,103,104],"C3~C9","C1~C9","C5~C9","C1~C4","C1、C2、C4","以下参与旁路激活途径的补体成分是"]